Syndax Pharmaceuticals, Inc. (SNDX)
17.60
-0.62
(-3.40%)
USD |
NASDAQ |
Oct 02, 16:00
17.62
+0.02
(+0.11%)
After-Hours: 20:00
Syndax Pharmaceuticals Price : 17.60 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 18.46 | 18.46 | 17.52 | 17.60 | 2.558M |
| Oct 01, 2026 | 18.56 | 18.87 | 18.05 | 18.22 | 1.432M |
| Sep 30, 2026 | 18.28 | 18.94 | 17.94 | 18.80 | 1.729M |
| Sep 29, 2026 | 17.90 | 18.31 | 17.75 | 18.24 | 1.499M |
| Sep 28, 2026 | 18.16 | 18.16 | 17.60 | 17.86 | 1.554M |
| Sep 25, 2026 | 18.03 | 18.35 | 17.76 | 18.20 | 1.343M |
| Sep 24, 2026 | 17.52 | 18.11 | 17.18 | 17.97 | 2.069M |
| Sep 23, 2026 | 18.20 | 18.47 | 17.09 | 17.64 | 2.087M |
| Sep 22, 2026 | 18.23 | 18.56 | 17.97 | 18.18 | 1.675M |
| Sep 21, 2026 | 17.74 | 18.45 | 17.39 | 18.07 | 2.108M |
| Sep 18, 2026 | 17.64 | 17.95 | 17.37 | 17.62 | 5.182M |
| Sep 17, 2026 | 17.53 | 18.05 | 17.37 | 17.68 | 2.582M |
| Sep 16, 2026 | 18.08 | 18.11 | 17.25 | 17.28 | 2.332M |
| Sep 15, 2026 | 18.19 | 18.19 | 17.71 | 18.09 | 1.128M |
| Sep 14, 2026 | 18.30 | 18.68 | 18.24 | 18.35 | 1.187M |
| Sep 11, 2026 | 19.01 | 19.02 | 18.02 | 18.18 | 1.223M |
| Sep 10, 2026 | 19.67 | 19.69 | 18.40 | 18.82 | 1.652M |
| Sep 09, 2026 | 19.82 | 20.20 | 19.69 | 19.84 | 1.237M |
| Sep 08, 2026 | 20.19 | 20.48 | 19.90 | 19.94 | 1.205M |
| Sep 04, 2026 | 20.46 | 21.00 | 20.46 | 20.56 | 1.361M |
| Sep 03, 2026 | 20.85 | 20.99 | 20.54 | 20.68 | 1.921M |
| Sep 02, 2026 | 20.23 | 21.00 | 19.96 | 20.78 | 2.016M |
| Sep 01, 2026 | 19.29 | 20.15 | 19.09 | 20.10 | 1.406M |
| Aug 31, 2026 | 19.44 | 19.46 | 19.00 | 19.29 | 1.396M |
| Aug 28, 2026 | 19.98 | 20.04 | 19.47 | 19.54 | 1.043M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| PS Ratio | 6.126 |
| Price to Book Value | 103.91 |
| Earnings Yield | -14.31% |
| Market Cap | 1.569B |